Medi Caps Ltd

Medi Caps Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medi Caps Ltd

₹ 26.7 0.53%
10 Jul - close price
medicaps.com BSE: 523144
About

Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]

Key Points

Business Overview:[1]
MCL operates in real estate as a parent company and pharma division through its wholly owned subsidiary. The company entered the real estate segment for city centric developments by way of Land acquisition and developing premium residential and commercial properties. It has almost completed its first project Medicaps Business Park and also sold ~50% of shops in the project

Website BSE
  • Market Cap ₹ 33.3 Cr.
  • Current Price ₹ 26.7
  • High / Low ₹ 47.0 / 21.0
  • Stock P/E
  • Book Value ₹ 89.5
  • Dividend Yield 0.00 %
  • ROCE -2.59 %
  • ROE -2.61 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.30 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -26.3% over past five years.
  • Company has a low return on equity of -2.19% over last 3 years.
  • Company has high debtors of 203 days.
  • Working capital days have increased from 638 days to 1,284 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
10.57 6.38 6.03 7.07 7.87 6.20 8.29 4.02 6.97 2.69 2.02 4.30 3.45
9.80 7.11 5.53 6.37 8.37 6.48 7.84 5.80 7.20 6.07 4.93 5.36 5.51
Operating Profit 0.77 -0.73 0.50 0.70 -0.50 -0.28 0.45 -1.78 -0.23 -3.38 -2.91 -1.06 -2.06
OPM % 7.28% -11.44% 8.29% 9.90% -6.35% -4.52% 5.43% -44.28% -3.30% -125.65% -144.06% -24.65% -59.71%
0.23 0.07 0.07 0.09 0.24 0.15 0.29 0.16 2.14 0.33 1.53 0.76 5.59
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 0.00 0.00 0.00
Depreciation 0.22 0.45 0.45 0.45 0.33 0.43 0.43 0.43 0.44 0.44 0.44 0.44 0.50
Profit before tax 0.78 -1.11 0.12 0.34 -0.59 -0.56 0.31 -2.05 1.45 -3.50 -1.82 -0.74 3.03
Tax % 53.85% 0.00% 0.00% 150.00% 83.05% 0.00% 0.00% 0.00% -18.62% 0.00% 0.00% 4.05% -0.33%
0.36 -1.11 0.12 -0.16 -1.08 -0.56 0.31 -2.05 1.72 -3.49 -1.82 -0.77 3.04
EPS in Rs 0.29 -0.89 0.10 -0.13 -0.87 -0.45 0.25 -1.64 1.38 -2.80 -1.46 -0.62 2.44
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
36.11 42.97 44.04 53.70 51.79 43.05 57.42 69.87 49.37 27.35 25.48 12.45
36.19 40.36 42.43 51.53 47.07 49.80 46.45 59.80 44.18 27.35 27.28 21.87
Operating Profit -0.08 2.61 1.61 2.17 4.72 -6.75 10.97 10.07 5.19 0.00 -1.80 -9.42
OPM % -0.22% 6.07% 3.66% 4.04% 9.11% -15.68% 19.10% 14.41% 10.51% 0.00% -7.06% -75.66%
1.29 0.68 2.02 1.07 2.73 2.86 1.77 1.95 1.49 0.48 2.73 8.21
Interest 0.66 0.06 0.10 0.10 0.13 0.12 0.10 0.11 0.13 0.04 0.05 0.01
Depreciation 1.81 1.80 1.81 1.79 1.82 1.83 1.52 1.81 1.74 1.69 1.72 1.81
Profit before tax -1.26 1.43 1.72 1.35 5.50 -5.84 11.12 10.10 4.81 -1.25 -0.84 -3.03
Tax % 63.49% 39.16% 20.35% 14.81% 2.18% 0.17% -0.09% 0.10% 63.62% 80.00% -32.14% 0.66%
-2.06 0.86 1.37 1.15 5.39 -5.85 11.13 10.08 1.76 -2.24 -0.57 -3.04
EPS in Rs -1.65 0.69 1.10 0.92 4.32 -4.69 8.93 8.08 1.41 -1.80 -0.46 -2.44
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -12%
5 Years: -26%
3 Years: -37%
TTM: -51%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -29%
Stock Price CAGR
10 Years: 2%
5 Years: -10%
3 Years: -11%
1 Year: -37%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: -2%
Last Year: -3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12.47 12.47 12.47 12.47 12.47 12.47 12.47 12.47 12.47 12.47 12.47 12.47
Reserves 68.94 69.80 76.62 77.75 83.13 78.48 92.24 103.79 106.10 108.51 108.81 99.14
0.81 0.08 0.09 0.17 0.12 0.06 0.00 0.00 0.00 0.00 0.00 0.00
7.00 10.68 8.19 10.52 10.89 4.20 10.11 14.09 7.42 6.31 4.14 3.85
Total Liabilities 89.22 93.03 97.37 100.91 106.61 95.21 114.82 130.35 125.99 127.29 125.42 115.46
58.05 56.41 62.14 61.03 59.80 57.30 58.12 59.31 58.91 58.65 57.18 55.21
CWIP 0.00 0.00 0.00 0.00 0.00 0.97 0.54 0.24 0.00 0.00 0.08 0.00
Investments 5.43 6.74 7.83 11.18 16.35 21.97 29.41 30.67 32.07 38.38 43.04 35.90
25.74 29.88 27.40 28.70 30.46 14.97 26.75 40.13 35.01 30.26 25.12 24.35
Total Assets 89.22 93.03 97.37 100.91 106.61 95.21 114.82 130.35 125.99 127.29 125.42 115.46

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
7.05 2.59 4.02 4.20 5.96 4.63 15.32 7.02 -6.08 6.94 5.07 -7.02
-6.97 -1.47 2.57 -4.09 -5.75 -5.80 -9.70 -4.08 -2.56 -7.73 -4.98 7.11
0.00 -0.73 -5.76 0.08 -0.05 -0.06 -0.06 0.00 0.00 0.00 0.00 0.00
Net Cash Flow 0.08 0.39 0.83 0.20 0.16 -1.23 5.56 2.95 -8.64 -0.79 0.09 0.09
Free Cash Flow 6.58 2.43 9.11 3.51 5.37 3.38 13.06 4.23 -7.24 6.59 4.74 -7.87
CFO/OP -9,750% 120% 270% 202% 128% -69% 140% 70% -58% -267% 74%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 87.33 82.48 74.09 88.57 90.56 37.39 40.62 52.61 62.55 144.40 125.92 202.88
Inventory Days 265.71 257.13 230.21 148.16 163.52 75.29 83.45 156.60 121.72 243.05 120.79 190.27
Days Payable 66.33 101.86 75.75 90.99 96.26 26.94 76.61 154.35 48.72 77.49 59.64 31.06
Cash Conversion Cycle 286.71 237.75 228.56 145.73 157.82 85.74 47.46 54.85 135.55 309.96 187.06 362.08
Working Capital Days 184.07 154.26 147.11 113.17 127.42 84.70 65.41 87.66 200.50 324.16 304.12 1,284.39
ROCE % -0.69% 1.81% 1.48% 1.56% 5.77% -6.58% 11.59% 8.78% 3.70% -1.17% -2.12% -2.59%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees on Roll
Count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Pharma Segment Revenue Share of Consolidated Revenue
%
Foreign Exchange Earnings from Exports
Rs. Lakhs ・Standalone data
Hard Gelatin Capsule Production Volume
Lakh units ・Standalone data
Hard Gelatin Capsule Sales Volume
Lakh units ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
50.13% 50.13% 50.13% 50.13% 50.13% 50.42% 50.61% 50.76% 50.76% 50.76% 50.76% 51.36%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02%
49.83% 49.84% 49.85% 49.84% 49.83% 49.54% 49.35% 49.21% 49.21% 49.19% 49.21% 48.61%
No. of Shareholders 14,56613,79013,22612,35611,73811,25511,17611,03310,85110,69210,49310,349

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports